Comorbidities and respiratory medications in the total COPD cohort (at study start) further split by the MRC dyspnoea grade (first recorded from study start).
Hana Müllerová
Chao Lu
Hao Li
Maggie Tabberer
10.1371/journal.pone.0085540.t003
https://plos.figshare.com/articles/dataset/_Comorbidities_and_respiratory_medications_in_the_total_COPD_cohort_at_study_start_further_split_by_the_MRC_dyspnoea_grade_first_recorded_from_study_start_/899268
<p>Percentages are based on row total. Comorbidities were searched for any time in the history before the observation period start; respiratory medications were searched for 12 months prior to study start. MRC scoring 1–5 equals to mMRC grades 0–4 with MRC 1 equals to mMRC 0.</p><p><sup>a</sup>≥4 treatments per year.</p><p>Abbreviations: COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroids; LABA, long-acting beta-blockers; LAMA, long-acting anticholinergics; MI, myocardial infarction; MRC, Medical Research Council; SABD, short-acting bronchodilators; SD, standard deviation.</p>
2014-01-10 02:44:27
Clinical research design
epidemiology
Diagnostic medicine
pathology
Clinical pathology
Clinical epidemiology
Non-clinical medicine
Health care policy
Health risk analysis
Pulmonology
Chronic obstructive pulmonary diseases
respiratory
medications
copd
cohort
further
mrc
dyspnoea
recorded